 |
 |
||||||
 |
Our customers' Feedback |
Your cart
$0.00 (0 items)
| |||||
| ||||||
- Hope and controversy over prostate cancer screening
Screening older men with the PSA blood test could cut prostate cancer deaths by around half, according to a new study.
- Antidepressant use rises as recession feeds wave of worry
The number of antidepressants prescribed by the NHS has almost doubled in the last decade, and rose sharply last year as the recession bit, figures reveal.
- Overtime could break your heart
Overtime is bad for the heart, according to researchers who followed the careers of more than 6,000 Whitehall civil servants.
- Premature ejaculation – there’s a pill for that!
On April 28, the world’s first premature ejaculation (PE) oral medication, Priligy (dapoxetine hydrochloride) will be available in the United Kingdom.
- Multivitamins may boost breast cancer risk
Women who regularly take multivitamins have a higher risk of breast cancer than women who don’t, according to a large new study.
Our billing is certified by:
- Childhood Cancer Leaves Cardiac Legacy - MedPage Today
MedIndiaChildhood Cancer Leaves Cardiac LegacyMedPage TodayThey found no evidence of cardiotoxicity for high-dose cyclophosphamide or ifosfamide.
- AIM: Childhood cancer survival may lead to later cardiac dysfunction - Cardiovascular Business
Health Care N DietAIM: Childhood cancer survival may lead to later cardiac dysfunctionCardiovascular BusinessThe researchers performed an echocardiography in patients who received anthracyclines, cardiac irradiation and high-doses of cyclophosphamide or .
- Rituximab May Not Be Superior to Cyclophosphamide for Vasculitis - Medscape
Rituximab May Not Be Superior to Cyclophosphamide for VasculitisMedscapeJuly 14, 2010 — A rituximab-based regimen was not superior to standard intravenous cyclophosphamide for severe antineutrophil cytoplasmic antibody .
- New Standard of Care Proposed for Follicular Lymphoma - Pharmacy Practice News (registration)
New Standard of Care Proposed for Follicular LymphomaPharmacy Practice News (registration)Of the patients, 75% received R-CHOP induction (rituximab plus cyclophosphamide, hydroxydaunorubicin, vincristine, prednisone), 22% R-CVP (rituximab plus .
- Rituximab approved for leukaemia on the NHS - WebMD.Boots.com
Rituximab approved for leukaemia on the NHSWebMD.
|
| Copyright © India Pharmacy Online. India Pharmacy, Indian Pharmacy, India Pharmacy Online, Indian Pharmacy Online. |